Bioinsights reports $2.75M sold toward a $7.9M equity offering
Travis Bond's Florida company reported seven investors and a $7.9M offering target; the filing records money sold, not a completed round.
By RuntimeWire Staff · Published
Primary source: SEC
Why it matters
Bond's filing records $2.75M sold, not a completed $7.9M round. Bioinsights' larger bet is that clinics will trust one platform to analyze patient data, suggest care and fulfill orders.
Bioinsights, led by Travis Bond, reported $2,747,698 in equity sold, according to a Form D filed on September 22nd. The filing sets a $7,897,697 total offering amount and says the first sale took place on September 13th. The larger figure is the offering target, not the amount raised.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.